16 results
PRE 14A
PRME
Prime Medicine Inc
19 Apr 24
Preliminary proxy
4:07pm
reporting;
establishing policies and procedures for the receipt and retention of accounting-related complaints and concerns;
recommending based upon … ,” if and when required, to be included in our annual proxy statement; and
reviewing and approving the retention or termination of any consulting firm
8-K
EX-1.1
PRME
Prime Medicine Inc
16 Feb 24
Entry into a Material Definitive Agreement
6:23am
such reports and financial statements to the Representatives to the extent they are filed on EDGAR.
(m) Record Retention. The Company will, pursuant
DEF 14A
PRME
Prime Medicine Inc
28 Apr 23
Definitive proxy
8:34am
for the receipt and retention of accounting-related complaints and concerns;
recommending based upon the audit committee’s review and discussions … and Analysis,” if and when required, to be included in our annual proxy statement; and
reviewing and approving the retention or termination of any
S-1
EX-10.6
etf3n8j9dq52w3cxahqe
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.7
khm2lb036w
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.14
oytik87e8r521z 6d0sr
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.13
y15gy x6p
23 Sep 22
IPO registration
4:12pm
S-1
EX-1.1
9oayfkztjamsrc2ui
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.4
wuyzgfafopz
23 Sep 22
IPO registration
4:12pm
DRS/A
EX-10.4
74cwwqki0viudoovffj3
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.6
tb8 r54a4
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.7
a6fatjz42c4h
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.14
1rfajto3 cx
12 Jan 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.13
frp8i6w
12 Jan 22
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next